BSECompany Update7 Oct 2026 · 7 Oct 2026, 02:02 pm
Please find attached signed Certifiacte for confirming compliance under Regulation 74(5) of the SEBI (DP) Regulations, for the quarter ended September 30, 2026.
Procter & Gamble Health Ltd · 500126
✦ AI SummaryRegulatory
Procter & Gamble Health Ltd has confirmed compliance under Regulation 74(5) of the SEBI (DP) Regulations for the quarter ended September 30, 2026, by furnishing details of securities dematerialized during the quarter to the stock exchanges.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
ec45298c-4f93-4e8e-905b-c73d9dd4efd6.pdf
View document text
Business Use
October 7, 2026
To, To,
The Corporate Relations Department The Listing Department
The BSE Limited The National Stock Exchange of India Limited
Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block,
Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East),
Dalal Street, Mumbai – 400001 Mumbai – 400051
Ref:- Scrip Code:- 500126 Ref:- Scrip Code:- PGHL
Dear Sir / Madam,
Subject: Certificate under Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018 for the quarter ended September 30, 2026.
With reference to above captioned subject, on the basis of confirmation received from our Registrar and
Transfer Agent, Kfin Technologies Limited, we confirm that the details of securities dematerialised during
the quarter ended September 30, 2026 as required under Regulation 74(5) of SEBI (Depositories and
Participants) Regulations, 2018, have been furnished to the stock exchanges where the shares of the
Company are listed within the prescribed time period.
We enclose herewith the copy of letter received from Kfin Technologies Limited confirming the above.
Kindly acknowledge receipt.
Thanking you,
Yours faithfully,
For Procter & Gamble Health Limited
Flavia Machado
Authorized Signatory
KFIN/MERK/CDSL/74(5) E/1
Date: 01‐10‐2026
CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED
REGD OFF: MARATHON FUTUREX, A WING
25TH FLOOR
NM JOSHI MARG
LOWER PAREL (EAST)
MUMBAI ‐ 400 023
Dear Sir(s),
Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026
We as Registrar to an Issue and Share Transfer Agent of the PROCTER & GAMBLE HEALTH LIMITED,
certify that the details of securities dematerialized/rematerialized during the aforesaid period, as
required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been
furnished to all the Stock Exchanges where the shares of the company are listed.
Thanking You
Yours faithfully,
for KFIN TECHNOLOGIES LIMITED
GANESH CHANDRA PATRO
DEPUTY VICE PRESIDENT
CC TO:
PROCTER & GAMBLE HEALTH LIMITED
GROUND FLOOR & FIRST FLOOR,
P&G PLAZA, CARDINAL GRACIAS ROAD,
CHAKALA, ANDHERI EAST,
MUMBAI
400099
KFIN/MERK/NSDL/74(5) E/1
Date: 01‐10‐2026
NATIONAL SECURITIES DEPOSITORY LIMITED
TRADE WORLD 4TH FLOOR
KAMALA MILLS COMPOUND
SENAPATI BAPAT MARG
LOWER PAREL
MUMBAI ‐ 400 013
Dear Sir(s),
Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026
We as Registrar to an Issue and Share Transfer Agent of the PROCTER & GAMBLE HEALTH LIMITED,
certify that the details of securities dematerialized/rematerialized during the aforesaid period, as
required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been
furnished to all the Stock Exchanges where the shares of the company are listed.
Thanking You
Yours faithfully,
for KFIN TECHNOLOGIES LIMITED
GANESH CHANDRA PATRO
DEPUTY VICE PRESIDENT
CC TO:
PROCTER & GAMBLE HEALTH LIMITED
GROUND FLOOR & FIRST FLOOR,
P&G PLAZA, CARDINAL GRACIAS ROAD,
CHAKALA, ANDHERI EAST,
MUMBAI
400099